These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

176 related articles for article (PubMed ID: 30354576)

  • 21. Differences in treatment, outcomes, and quality of life among patients with heart failure in Canada and the United States.
    Kaul P; Reed SD; Hernandez AF; Howlett JG; Ezekowitz JA; Li Y; Zheng Y; Rouleau JL; Starling RC; O'Connor CM; Califf RM; Armstrong PW
    JACC Heart Fail; 2013 Dec; 1(6):523-30. PubMed ID: 24622005
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Markers of decongestion, dyspnea relief, and clinical outcomes among patients hospitalized with acute heart failure.
    Kociol RD; McNulty SE; Hernandez AF; Lee KL; Redfield MM; Tracy RP; Braunwald E; O'Connor CM; Felker GM;
    Circ Heart Fail; 2013 Mar; 6(2):240-5. PubMed ID: 23250981
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Natriuretic peptide-guided therapy in chronic heart failure: a meta-analysis of 2,686 patients in 12 randomized trials.
    Savarese G; Trimarco B; Dellegrottaglie S; Prastaro M; Gambardella F; Rengo G; Leosco D; Perrone-Filardi P
    PLoS One; 2013; 8(3):e58287. PubMed ID: 23472172
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Nesiritide in acute decompensated heart failure: a pooled analysis of randomized controlled trials.
    Abraham WT; Trupp RJ; Jarjoura D
    Clin Cardiol; 2010 Aug; 33(8):484-9. PubMed ID: 20734445
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Body Weight Change During and After Hospitalization for Acute Heart Failure: Patient Characteristics, Markers of Congestion, and Outcomes: Findings From the ASCEND-HF Trial.
    Ambrosy AP; Cerbin LP; Armstrong PW; Butler J; Coles A; DeVore AD; Dunlap ME; Ezekowitz JA; Felker GM; Fudim M; Greene SJ; Hernandez AF; O'Connor CM; Schulte P; Starling RC; Teerlink JR; Voors AA; Mentz RJ
    JACC Heart Fail; 2017 Jan; 5(1):1-13. PubMed ID: 28034373
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Rationale and design of the pilot randomized study of nesiritide versus dobutamine in heart failure (PRESERVD-HF).
    Gheorghiade M; Gattis WA; Adams KF; Jaffe AS; O'Connor CM; ;
    Am Heart J; 2003 Feb; 145(2 Suppl):S55-7. PubMed ID: 12594453
    [No Abstract]   [Full Text] [Related]  

  • 27. Rationale and design of the Acute Study of Clinical Effectiveness of Nesiritide in Decompensated Heart Failure Trial (ASCEND-HF).
    Hernandez AF; O'Connor CM; Starling RC; Reist CJ; Armstrong PW; Dickstein K; Lorenz TJ; Gibler WB; Hasselblad V; Komajda M; Massie B; McMurray JJ; Nieminen M; Rouleau JL; Swedberg K; Califf RM
    Am Heart J; 2009 Feb; 157(2):271-7. PubMed ID: 19185633
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Phase 3 DREAM-HF Trial of Mesenchymal Precursor Cells in Chronic Heart Failure.
    Borow KM; Yaroshinsky A; Greenberg B; Perin EC
    Circ Res; 2019 Jul; 125(3):265-281. PubMed ID: 31318648
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Arrival by ambulance in acute heart failure: insights into the mode of presentation from Acute Studies of Nesiritide in Decompensated Heart Failure (ASCEND-HF).
    Ezekowitz JA; Podder M; Hernandez AF; Armstrong PW; Starling RC; O'Connor CM; Califf RM
    BMJ Open; 2016 Mar; 6(3):e010201. PubMed ID: 26988350
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Nesiritide and Me.
    Kittleson MM
    Circ Heart Fail; 2018 Aug; 11(8):e005440. PubMed ID: 30354567
    [No Abstract]   [Full Text] [Related]  

  • 31. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
    Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
    Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Short and long-term mortality with nesiritide.
    Arora RR; Venkatesh PK; Molnar J
    Am Heart J; 2006 Dec; 152(6):1084-90. PubMed ID: 17161057
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Impact of acute serum creatinine elevation in patients treated with nesiritide.
    Elkayam U; Janmohamed M; Hatamizadeh P; Heywood JT; Wei LJ; Mills RM
    Clin Cardiol; 2009 Apr; 32(4):215-9. PubMed ID: 19353723
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Efficacy and safety of nesiritide in patients with acute decompensated heart failure.
    DeWald TA; Hernandez AF
    Expert Rev Cardiovasc Ther; 2010 Feb; 8(2):159-69. PubMed ID: 20136602
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Outcomes associated with vasoactive therapy in patients with acute decompensated heart failure.
    Arnold LM; Crouch MA; Carroll NV; Oinonen MJ
    Pharmacotherapy; 2006 Aug; 26(8):1078-85. PubMed ID: 16863484
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Post-discharge prognosis of patients admitted to hospital for heart failure by world region, and national level of income and income disparity (REPORT-HF): a cohort study.
    Tromp J; Bamadhaj S; Cleland JGF; Angermann CE; Dahlstrom U; Ouwerkerk W; Tay WT; Dickstein K; Ertl G; Hassanein M; Perrone SV; Ghadanfar M; Schweizer A; Obergfell A; Lam CSP; Filippatos G; Collins SP
    Lancet Glob Health; 2020 Mar; 8(3):e411-e422. PubMed ID: 32087174
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Use of nesiritide before and after publications suggesting drug-related risks in patients with acute decompensated heart failure.
    Hauptman PJ; Schnitzler MA; Swindle J; Burroughs TE
    JAMA; 2006 Oct; 296(15):1877-84. PubMed ID: 17047218
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Effects of nesiritide and predictors of urine output in acute decompensated heart failure: results from ASCEND-HF (acute study of clinical effectiveness of nesiritide and decompensated heart failure).
    Gottlieb SS; Stebbins A; Voors AA; Hasselblad V; Ezekowitz JA; Califf RM; O'Connor CM; Starling RC; Hernandez AF
    J Am Coll Cardiol; 2013 Sep; 62(13):1177-83. PubMed ID: 23747790
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Multimorbidity in patients with acute heart failure across world regions and country income levels (REPORT-HF): a prospective, multicentre, global cohort study.
    Gerhardt T; Gerhardt LMS; Ouwerkerk W; Roth GA; Dickstein K; Collins SP; Cleland JGF; Dahlstrom U; Tay WT; Ertl G; Hassanein M; Perrone SV; Ghadanfar M; Schweizer A; Obergfell A; Filippatos G; Lam CSP; Tromp J; Angermann CE
    Lancet Glob Health; 2023 Dec; 11(12):e1874-e1884. PubMed ID: 37973338
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Impact of Human Development Index on the profile and outcomes of patients with acute coronary syndrome.
    Roy A; Roe MT; Neely ML; Cyr DD; Zamoryakhin D; Fox KA; White HD; Armstrong PW; Ohman EM; Prabhakaran D
    Heart; 2015 Feb; 101(4):279-86. PubMed ID: 25538134
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.